Showing results (31-40 of 357) with videos related to
Sort By:
Pageof 36
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 6, 2002
[A case of papulonecrotic tuberculide preceded by pulmonary tuberculosis]Masaki Fujita, Yoichi Nakanishi, Koichiro Yoshida, et al.Respirology (Carlton, Vic.)|May 26, 2010
Incidence of hypertrophic pulmonary osteoarthropathy associated with primary lung cancerMiiru Izumi, Koichi Takayama, Hidetake Yabuuchi, et al.BMC Cancer|August 2, 2012
Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non-small cell lung cancer (WJOG 5910L)Masayuki Takeda, Isamu Okamoto, Takeharu Yamanaka, et al.International Journal of Molecular Sciences|August 3, 2016
Urinary Dopamine as a Potential Index of the Transport Activity of Multidrug and Toxin Extrusion in the KidneyMoto Kajiwara, Tsuyoshi Ban, Kazuo Matsubara, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Enhancement of antigen-presenting capacity and antitumor immunity of dendritic cells pulsed with autologous tumor-derived RNA in miceTakahiro Minami, Yoichi Nakanishi, Miiru Izumi, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 29, 2010
A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosisSatoshi Ikegame, Kentaro Wakamatsu, Masaki Fujita, et al.Oncology Reports|April 8, 2010
Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese populationChikako Kiyohara, Takahiko Horiuchi, Yoshihiro Miyake, et al.Molecules (Basel, Switzerland)|June 24, 2022
Precise Quantification of Molybdate In Vitro by the FRET-Based Nanosensor 'MolyProbe'Kevin D Oliphant, Marius Karger, Yoichi Nakanishi, et al.Clinical Therapeutics|November 13, 2018
Academia-industry Cooperation in the Medical Field: Matching Opportunities in JapanNao Tsuruya, Toshio Kawashima, Masataka Shiozuka, et al.Oncotargets and Therapy|March 14, 2014
Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancerEiji Iwama, Isamu Okamoto, Taishi Harada, et al.Pageof 36